Long noncoding RNA PVT1 facilitates cervical cancer progression via negative regulating of miR-424

Oncology Research

Volumn 25, Issue 8, 2017, Pages 1391-1398

  Gao, Ya Li ^a   Zhao, Zi Shen ^b   Zhang, Ming Yun ^a   Han, Li Jie ^a   Dong, Yu Jin ^c   Xu, Bo ^c  

^a CANGZHOU CENTRAL HOSPITAL   (China)

^b Cangzhou People's Hospital   (China)

^c ZIBO CENTRAL HOSPITAL   (China)

Author keywords

Cervical cancer; Competing endogenous RNA (ceRNA); miR 424; Plasmacytoma variant translocation 1 (PVT1)

Indexed keywords

LONG UNTRANSLATED RNA; MICRORNA; MICRORNA 424; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; MIRN424 MICRORNA, HUMAN; PVT1 LONG-NON-CODING RNA, HUMAN;

ARTICLE; BIOINFORMATICS; CANCER GROWTH; CANCER INHIBITION; CANCER TISSUE; CERVICAL CANCER CELL LINE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE SILENCING; HUMAN; HUMAN CELL; LUCIFERASE ASSAY; PLASMACYTOMA VARIANT TRANSLOCATION 1 GENE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; UPREGULATION; UTERINE CERVIX CANCER; DISEASE EXACERBATION; GENETIC TRANSFECTION; GENETICS; HELA CELL LINE; METABOLISM; METASTASIS; PATHOLOGY; TUMOR CELL LINE; UTERINE CERVIX TUMOR;

CELL LINE, TUMOR; DISEASE PROGRESSION; FEMALE; HELA CELLS; HUMANS; MICRORNAS; NEOPLASM METASTASIS; RNA, LONG NONCODING; TRANSFECTION; UP-REGULATION; UTERINE CERVICAL NEOPLASMS;

EID: 85019347654     PISSN: 09650407     EISSN: 15553906     Source Type: Journal    
DOI: 10.3727/096504017X14881559833562     Document Type: Article

References (21)

1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.
2. Grat K, Grat M, Wronka KM, Pietrzak B, Suchonska B, Walter de Walthoffen S, Mlynarczyk G, Krawczyk M, Wielgos M. Cervical human papilloma virus infection in the early postoperative period after liver transplantation: Prevalence, risk factors, and concordance with anal infections. Clin Transplant. 2017;31(3).
3. Teymouri M, Pirro M, Johnston TP, Sahebkar A. Curcumin as a multifaceted compound against human papilloma virus infection and cervical cancers: A review of chemistry, cellular, molecular, and preclinical features. Biofactors 2017;43(3):331–46.
4. Peralta-Zaragoza O, Deas J, Meneses-Acosta A, De la OGF, Fernandez-Tilapa G, Gomez-Ceron C, Benitez-Boijseauneau O, Burguete-Garcia A, Torres-Poveda K, Bermudez-Morales VH, Madrid-Marina V, Rodríguez-Dorantes M, Hidalgo-Miranda A, Pérez-Plasencia C. Relevance of miR-21 in regulation of tumor suppressor gene PTEN in human cervical cancer cells. BMC Cancer 2016;16:215.
5. Zhao X, Li X, Ren Q, Tian J, Chen J. Calycosin induces apoptosis in colorectal cancer cells, through modulating the ERbeta/MiR-95 and IGF-1R, PI3K/Akt signaling pathways. Gene 2016;591(1):123–8.
6. Kobayashi R, Miyagawa R, Yamashita H, Morikawa T, Okuma K, Fukayama M, Ohtomo K, Nakagawa K. Increased expression of long non-coding RNA XIST predicts favorable prognosis of cervical squamous cell carcinoma subsequent to definitive chemoradiation therapy. Oncol Lett. 2016;12(5):3066–74.
7. McHugh CA, Chen CK, Chow A, Surka CF, Tran C, McDonel P, Pandya-Jones A, Blanco M, Burghard C, Moradian A, Sweredoski MJ, Shishkin AA, Su J, Lander ES, Hess S, Plath K, Guttman M. The Xist lncRNA interacts directly with SHARP to silence transcription through HDAC3. Nature 2015;521(7551):232–6.
8. Richard JL, Ogawa Y. Understanding the complex circuitry of lncRNAs at the X-inactivation Center and its implications in disease conditions. Curr Top Microbiol Immunol. 2016;394:1–27.
9. Xia S, Wang C, Ni X, Ni Z, Dong Y, Zhan W. NONHSAT076754 aids ultrasonography in predicting lymph node metastasis and promotes migration and invasion of papillary thyroid cancer cells. Oncotarget 2017; 8(2):2293–306.
10. Iden M, Fye S, Li K, Chowdhury T, Ramchandran R, Rader JS. The lncRNA PVT1 contributes to the cervical cancer phenotype and associates with poor patient prognosis. PLoS One 2016;11(5):e0156274.
11. Zhang S, Zhang G, Liu J. Long noncoding RNA PVT1 promotes cervical cancer progression through epigenetically silencing miR-200b. APMIS 2016;124(8):649–58.
12. Wang X, Li Q, Jin H, Zou H, Xia W, Dai N, Dai XY, Wang D, Xu CX, Qing Y. miR–424 acts as a tumor radiosensitizer by targeting aprataxin in cervical cancer. Oncotarget 2016;7(47):77508–15.
13. Zhou Y, An Q, Guo RX, Qiao YH, Li LX, Zhang XY, Zhao XL. MiR424-5p functions as an anti-oncogene in cervical cancer cell growth by targeting KDM5B via the Notch signaling pathway. Life Sci. 2017;171:9–15.
14. Degirmenci U, Lei S. Role of lncRNAs in cellular aging. Front Endocrinol. (Lausanne) 2016;7:151.
15. He R, Hu Z, Wang Q, Luo W, Li J, Duan L, Zhu YS, Luo DX. The role of long non-coding RNAs in nasopharyngeal carcinoma: A systemic review. Oncotarget 2017;8(9):16075–83.
16. Pan Y, Li C, Chen J, Zhang K, Chu X, Wang R, Chen L. The emerging roles of long noncoding RNA ROR (lincRNA-ROR) and its possible mechanisms in human cancers. Cell Physiol Biochem. 2016;40(1–2):219–29.
17. Li T, Mo X, Fu L, Xiao B, Guo J. Molecular mechanisms of long noncoding RNAs on gastric cancer. Oncotarget 2016;7(8):8601–12.
18. Yang YR, Zang SZ, Zhong CL, Li YX, Zhao SS, Feng XJ. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer. Int J Clin Exp Pathol. 2014;7(10):6929–35.
19. Austin PJ, Tsitsiou E, Boardman C, Jones SW, Lindsay MA, Adcock IM, Chung KF, Perry MM. Transcriptional profiling identifies the long noncoding RNA plasmacytoma variant translocation (PVT1) as a novel regulator of the asthmatic phenotype in human airway smooth muscle. J Allergy Clin Immunol. 2017;139(3):780–9.
20. Xu J, Li Y, Wang F, Wang X, Cheng B, Ye F, Xie X, Zhou C, Lu W. Suppressed miR-424 expression via upregulation of target gene Chk1 contributes to the progression of cervical cancer. Oncogene 2013;32(8):976–87.
21. Huang T, Liu HW, Chen JQ, Wang SH, Hao LQ, Liu M, Wang B. The long noncoding RNA PVT1 functions as a competing endogenous RNA by sponging miR-186 in gastric cancer. Biomed Pharmacother. 2017;88:302–8.